Amina Salkić
A5018483920- Pulmonary Hypertension Research and Treatments
- Long-Term Effects of COVID-19
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Healthcare Policy and Management
- Cardiovascular Issues in Pregnancy
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Acute Myocardial Infarction Research
- Respiratory Support and Mechanisms
- COVID-19 and Mental Health
- COVID-19 Clinical Research Studies
University Hospital Heidelberg
2022-2023
Heidelberg University
2022-2023
German Center for Lung Research
2022-2023
Abstract Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to investigate the clinical implications post-PE impairment (PPEI) fulfilling prospectively defined criteria. Methods results A prospective multicentre observational cohort study was conducted in 17 large-volume centres across Germany. Adult consecutive patients with confirmed symptomatic PE were followed a standardized assessment plan pre-defined visits at 3, 12, 24 months. The co-primary (i) diagnosis...
Abstract Aims Patients surviving acute pulmonary embolism (PE) necessitate long-term treatment and follow-up. We estimated, the chronic economic impact of PE on German healthcare system. Methods results calculated direct cost illness during first year after discharge for index PE, analysing data from a multicentre prospective cohort study in Germany. Main accompanying readmission diagnoses were used to calculate DRG-based hospital reimbursements; anticoagulation costs estimated exact...
Abstract Background Epoprostenol AS (Veletri ® ), a thermostable epoprostenol formulation, provides better drug stability and improved clinical use compared to previous formulations. This study aims expand experience in the of Veletri , especially regarding tolerability, safety survival. Methods Pulmonary arterial hypertension (PAH) patients at high risk despite pretreatment with least double oral combination therapy indication for ) treatment were consecutively included this prospective,...
Persistent symptoms after acute coronavirus-disease-2019 (COVID-19) are common, and there is no significant correlation with the severity of disease. In long-COVID (persistent >4 weeks COVID-19), respiratory frequent, but lung function testing shows only mild changes that do not explain symptoms. Although COVID-19 may lead to an impairment peripheral nervous system skeletal muscles, muscle has been examined in this setting.In study, we assessed dyspnea (NYHA-function class) patients analyzed...
Hintergrund: Anhaltende Symptome nach akuter Coronavirus-Krankheit-2019 (COVID-19) sind häufig und es besteht kein signifikanter Zusammenhang mit der Schwere akuten Erkrankung. Bei Long COVID (anhaltende > 4 Wochen COVID-19) treten respiratorische auf, aber Lungenfunktionstests zeigen nur leichte Veränderungen, die nicht erklären. Obwohl COVID-19 zu einer Beeinträchtigung des peripheren Nervensystems Skelettmuskulatur führen kann, wurde Funktion Atemmuskulatur in diesem untersucht....